Limoges, France

Fabrice Billet

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Université De Limoges. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fabrice Billet. Retrieved from https://idiyas.com/inventor/fabrice-billet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fabrice Billet: Research on a Curcumin-Based Approach to Peripheral Neuropathies.

Introduction

Fabrice Billet is an inventor associated with Université de Limoges in Limoges, France. His patent work describes a cellulose–cyclodextrin–curcumin complex intended for potential use in treating peripheral neuropathies.

Latest Patents

Billet is associated with 1 patent: “Therapeutic Potential of Cellulose-Cyclodextrin-Curcumin Nanocrystals in the Treatment of Peripheral Neuropathies.” The patent discloses a complex containing cellulose nanocrystals, at least one β-cyclodextrin molecule, and at least one curcumin molecule. It also describes a pharmaceutical composition containing the complex and a pharmaceutically acceptable excipient.

The disclosed approaches include formulations such as hydrogels, subcutaneous implants, implantable pumps, and implanted biofunctionalized nerve conduits. These formats are proposed to support treatment compliance, extended release, and improved pharmacokinetics.

Career Highlights

Billet’s listed patent connects his work with research at Université de Limoges. The invention focuses on a potential therapeutic delivery system for peripheral neuropathies.

Collaborations

The supplied information identifies Martial Caillaud and Franck Sturtz as Billet’s coworkers.

Conclusion

Fabrice Billet’s patent describes a cellulose–cyclodextrin–curcumin complex and possible delivery formats aimed at advancing treatment approaches for peripheral neuropathies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…